206. Fragile X syndrome Clinical trials / Disease details


Clinical trials : 108 Drugs : 91 - (DrugBank : 36) / Drug target genes : 52 - Drug target pathways : 77

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05030129
(ClinicalTrials.gov)
October 7, 20215/8/2021Single Blind Study of Ergoloid Mesylates, 5-HTP and the Combination in Adult Males With Fragile X SyndromeAn Exploratory Single Blind Study of Ergoloid Mesylates, 5-Hydroxytryptophan, and the Combination in Adult Males With Fragile X SyndromeFragile X SyndromeDietary Supplement: 5-Hydroxytryptophan / Vitamin B6;Drug: Ergoloid Mesylate;Other: PlaceboElizabeth Berry-KravisNULLRecruiting18 Years45 YearsMale15Phase 2United States